1. Home
  2. IGIC vs AVDL Comparison

IGIC vs AVDL Comparison

Compare IGIC & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

HOLD

Current Price

$25.35

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.57

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGIC
AVDL
Founded
2001
2015
Country
Jordan
Ireland
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
IGIC
AVDL
Price
$25.35
$21.57
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$30.33
$18.38
AVG Volume (30 Days)
40.0K
1.6M
Earning Date
11-04-2025
11-04-2025
Dividend Yield
4.12%
N/A
EPS Growth
N/A
N/A
EPS
2.81
N/A
Revenue
$525,808,999.00
$248,517,000.00
Revenue This Year
$17.79
$65.47
Revenue Next Year
$3.05
$30.88
P/E Ratio
$9.06
N/A
Revenue Growth
N/A
79.88
52 Week Low
$20.82
$6.38
52 Week High
$27.76
$23.57

Technical Indicators

Market Signals
Indicator
IGIC
AVDL
Relative Strength Index (RSI) 72.24 60.27
Support Level $25.01 $21.36
Resistance Level $25.70 $21.67
Average True Range (ATR) 0.37 0.12
MACD 0.04 -0.10
Stochastic Oscillator 89.39 70.89

Price Performance

Historical Comparison
IGIC
AVDL

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: